Authors:
PRIVITERA MD
FRENCH JA
MCCARTHY MB
ALDERFER VB
PETERS GR
MEANS ED
Citation: Md. Privitera et al., TOLERABILITY AND SAFETY OF HIGH-DOSE REMACEMIDE HYDROCHLORIDE AS ADJUNCTIVE THERAPY IN PATIENTS WITH REFRACTORY EPILEPSY, Neurology, 50(4), 1998, pp. 64002-64002
Authors:
GIDAL BE
CRISMON ML
WAGNER ML
FAGAN SC
PRIVITERA MD
DALMADYISRAEL C
GRAVES NM
Citation: Be. Gidal et al., CURRENT DEVELOPMENTS IN NEUROLOGY .2. ADVANCES IN THE PHARMACOTHERAPYOF ALZHEIMER-DISEASE, PARKINSON DISEASE, AND STROKE, The Annals of pharmacotherapy, 30(12), 1996, pp. 1446-1451
Authors:
GIDAL BE
WAGNER ML
PRIVITERA MD
DALMADYISRAEL C
CRISMON ML
FAGAN SC
GRAVES NM
Citation: Be. Gidal et al., CURRENT DEVELOPMENTS IN NEUROLOGY .1. ADVANCES IN THE PHARMACOTHERAPYOF HEADACHE, EPILEPSY, AND MULTIPLE-SCLEROSIS, The Annals of pharmacotherapy, 30(11), 1996, pp. 1272-1276
Citation: Lm. Arnold et Md. Privitera, PSYCHOPATHOLOGY AND TRAUMA IN EPILEPTIC AND PSYCHOGENIC SEIZURE PATIENTS, Psychosomatics, 37(5), 1996, pp. 438-443
Citation: R. Jooma et al., LESIONECTOMY VERSUS ELECTROPHYSIOLOGICALLY GUIDED RESECTION FOR TEMPORAL-LOBE TUMORS MANIFESTING WITH COMPLEX PARTIAL SEIZURES, Journal of neurosurgery, 83(2), 1995, pp. 231-236
Authors:
STRAWSBURG RH
OUAISS IE
PRIVITERA MD
DHAWAN AP
Citation: Rh. Strawsburg et al., USE OF ARTIFICIAL NEURAL NETWORKS TO INTERPRET CLINICAL AND NEUROPSYCHOLOGIC TESTING DATA, Epilepsia, 36, 1995, pp. 121-121